First positronium image of the human brain

P. Moskal,J. Baran,S. Bass,J. Choiński,N. Chug,C. Curceanu,E. Czerwiński,M. Dadgar,M. Das,K. Dulski,K.V. Eliyan,K. Fronczewska,A. Gajos,K. Kacprzak,M. Kajetanowicz,T. Kaplanoglu,Ł. Kapłon,K. Klimaszewski,M. Kobylecka,G. Korcyl,T. Kozik,W. Krzemień,K. Kubat,D. Kumar,J. Kunikowska,J. Mączewska,W. Migdał,G. Moskal,W. Mryka,S. Niedźwiecki,S. Parzych,E. Perez del Rio,L. Raczyński,S. Sharma,Shivani,R.Y. Shopa,M. Silarski,M. Skurzok,F. Tayefi,K. Tayefi,P. Tanty,W. Wiślicki,L. Królicki,E. Ł. Stępień
DOI: https://doi.org/10.1101/2024.02.01.23299028
2024-02-03
Abstract:Positronium, an unstable atom consisting of an electron and a positron, is abundantly produced within the molecular voids of a patient’s body during positron emission tomography (PET) diagnosis. Its properties, such as its average lifetime between formation and annihilation into photons, dynamically respond to the submolecular architecture of the tissue and the partial pressure of oxygen molecules. However, the diagnostic information that positronium may deliver about early molecular alterations remains unavailable in clinics with state-of-the-art PET scanners. This study presents the first images of positronium lifetime in humans. We developed a dedicated J-PET system with multiphoton detection capability for imaging. The measurements of positronium lifetime were performed on a patient with a glioblastoma tumor in the brain. The patient was injected intratumorally with the Ga radionuclide attached to Substance-P, which accumulates in glioma cells, and intravenously with Ga attached to the PSMA-11 ligand, which is selective to glioma cells and salivary glands. The Ga radionuclide is routinely used in PET for detecting radiopharmaceutical accumulation and was applied for positronium imaging because it can emit an additional prompt gamma. The prompt gamma enables the determination of the time of positronium formation, while the photons from positronium annihilation were used to reconstruct the place and time of its decay. The determined positronium mean lifetime in glioblastoma cells is shorter than in salivary glands, which in turn is shorter than in healthy brain tissues, demonstrating for the first time that positronium imaging can be used to diagnose disease . This study also demonstrates that if current total-body PET systems were equipped with multiphoton detection capability and the Sc radionuclide was applied, it would be possible to perform positronium imaging at 6500 times greater sensitivity than achieved in this research. Therefore, it is anticipated that positronium imaging has the potential to bring a new quality of cancer diagnosis in clinics.
Radiology and Imaging
What problem does this paper attempt to address?
This paper presents the first application of positronium imaging in vivo in the human brain. Positronium imaging is a method that studies the distribution of substances in the body by detecting photons produced by the annihilation of positrons and electrons. In PET scans, positrons collide with electrons to annihilate, but they can also form unstable positronium with a lifetime dependent on the environment. The researchers developed a specialized J-PET system that can simultaneously detect annihilation photons and prompt gamma rays, and used it to image the positronium lifetime in a patient with a glioblastoma. The patient was injected with a drug labeled with the radioactive isotope 68Ga, which emits additional prompt gamma rays upon positron annihilation. These rays can be used to determine the formation and decay time of positronium. The results showed that the average lifetime of positronium in glioblastoma was shorter than that in the salivary gland, and even shorter in healthy brain tissue. This suggests that positronium imaging can be used for disease diagnosis and may provide diagnostic information in the early stages of molecular changes, improving the specificity of cancer diagnosis. The paper also discusses the potential of using a current whole-body PET system equipped with multiphoton detection capabilities and using the radioactive isotope 44Sc for higher sensitivity positronium imaging, greatly enhancing the quality of cancer diagnosis. Despite the statistical uncertainty in the current study, the potential of this imaging technique indicates its future widespread application in clinical medicine.